1 Market Overview
1.1 Atezolizumab Introduction
1.2 Market Analysis by Type
1.2.1 Use: Single Drug
1.2.2 Use: Chemotherapy Combination
1.3 Market Analysis by Applications
1.3.1 Bladder Cancer
1.3.2 Lung Cancer
1.3.3 Advanced Triple-negative Breast Cancer
1.3.4 Head and Neck Cancer
1.3.5 Urothelial Carcinoma
1.3.6 Renal Cell Carcinoma
1.3.7 Hepatocellular Carcinoma (HCC)
1.3.8 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2015-2025)
1.4.1.2 Canada Market States and Outlook (2015-2025)
1.4.1.3 Mexico Market States and Outlook (2015-2025)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2015-2025)
1.4.2.2 France Market States and Outlook (2015-2025)
1.4.2.3 UK Market States and Outlook (2015-2025)
1.4.2.4 Russia Market States and Outlook (2015-2025)
1.4.2.5 Italy Market States and Outlook (2015-2025)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2015-2025)
1.4.3.2 Japan Market States and Outlook (2015-2025)
1.4.3.3 Korea Market States and Outlook (2015-2025)
1.4.3.4 India Market States and Outlook (2015-2025)
1.4.3.5 Southeast Asia Market States and Outlook (2015-2025)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2015-2025)
1.4.4.2 Egypt Market States and Outlook (2015-2025)
1.4.4.3 Saudi Arabia Market States and Outlook (2015-2025)
1.4.4.4 South Africa Market States and Outlook (2015-2025)
1.4.4.5 Turkey Market States and Outlook (2015-2025)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Genentech (Roche)
2.1.1 Business Overview
2.1.2 Atezolizumab Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Genentech (Roche) Atezolizumab Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
3 Global Atezolizumab Sales, Revenue, Market Share and Competition by Manufacturer (2017-2019)
3.1 Global Atezolizumab Sales and Market Share by Manufacturer (2017-2019)
3.2 Global Atezolizumab Revenue and Market Share by Manufacturer (2017-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Atezolizumab Manufacturer Market Share in 2019
3.3.2 Top 6 Atezolizumab Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Atezolizumab Market Analysis by Regions
4.1 Global Atezolizumab Sales, Revenue and Market Share by Regions
4.1.1 Global Atezolizumab Sales and Market Share by Regions (2015-2019)
4.1.2 Global Atezolizumab Revenue and Market Share by Regions (2015-2019)
4.2 North America Atezolizumab Sales and Growth Rate (2015-2019)
4.3 Europe Atezolizumab Sales and Growth Rate (2015-2019)
4.4 Asia-Pacific Atezolizumab Sales and Growth Rate (2015-2019)
4.5 South America Atezolizumab Sales and Growth Rate (2015-2019)
4.6 Middle East and Africa Atezolizumab Sales and Growth Rate (2015-2019)
5 North America Atezolizumab by Country
5.1 North America Atezolizumab Sales, Revenue and Market Share by Country
5.1.1 North America Atezolizumab Sales and Market Share by Country (2015-2019)
5.1.2 North America Atezolizumab Revenue and Market Share by Country (2015-2019)
5.2 United States Atezolizumab Sales and Growth Rate (2015-2019)
5.3 Canada Atezolizumab Sales and Growth Rate (2015-2019)
5.4 Mexico Atezolizumab Sales and Growth Rate (2015-2019)
6 Europe Atezolizumab by Country
6.1 Europe Atezolizumab Sales, Revenue and Market Share by Country
6.1.1 Europe Atezolizumab Sales and Market Share by Country (2015-2019)
6.1.2 Europe Atezolizumab Revenue and Market Share by Country (2015-2019)
6.2 Germany Atezolizumab Sales and Growth Rate (2015-2019)
6.3 UK Atezolizumab Sales and Growth Rate (2015-2019)
6.4 France Atezolizumab Sales and Growth Rate (2015-2019)
6.5 Russia Atezolizumab Sales and Growth Rate (2015-2019)
6.6 Italy Atezolizumab Sales and Growth Rate (2015-2019)
7 Asia-Pacific Atezolizumab by Country
7.1 Asia-Pacific Atezolizumab Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Atezolizumab Sales and Market Share by Country (2015-2019)
7.1.2 Asia-Pacific Atezolizumab Revenue and Market Share by Country (2015-2019)
7.2 China Atezolizumab Sales and Growth Rate (2015-2019)
7.3 Japan Atezolizumab Sales and Growth Rate (2015-2019)
7.4 Korea Atezolizumab Sales and Growth Rate (2015-2019)
7.5 India Atezolizumab Sales and Growth Rate (2015-2019)
7.6 Southeast Asia Atezolizumab Sales and Growth Rate (2015-2019)
8 South America Atezolizumab by Country
8.1 South America Atezolizumab Sales, Revenue and Market Share by Country
8.1.1 South America Atezolizumab Sales and Market Share by Country (2015-2019)
8.1.2 South America Atezolizumab Revenue and Market Share by Country (2015-2019)
8.2 Brazil Atezolizumab Sales and Growth Rate (2015-2019)
8.3 Argentina Atezolizumab Sales and Growth Rate (2015-2019)
8.4 Colombia Atezolizumab Sales and Growth Rate (2015-2019)
9 Middle East and Africa Atezolizumab by Countries
9.1 Middle East and Africa Atezolizumab Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Atezolizumab Sales and Market Share by Country (2015-2019)
9.1.2 Middle East and Africa Atezolizumab Revenue and Market Share by Country (2015-2019)
9.2 Saudi Arabia Atezolizumab Sales and Growth Rate (2015-2019)
9.3 Turkey Atezolizumab Sales and Growth Rate (2015-2019)
9.4 Egypt Atezolizumab Sales and Growth Rate (2015-2019)
9.5 Nigeria Atezolizumab Sales and Growth Rate (2015-2019)
9.6 South Africa Atezolizumab Sales and Growth Rate (2015-2019)
10 Global Atezolizumab Market Segment by Type
10.1 Global Atezolizumab Sales, Revenue and Market Share by Type (2015-2019)
10.1.1 Global Atezolizumab Sales and Market Share by Type (2015-2019)
10.1.2 Global Atezolizumab Revenue and Market Share by Type (2015-2019)
10.2 Use: Single Drug Sales Growth and Price
10.2.1 Global Use: Single Drug Sales Growth (2015-2019)
10.2.2 Global Use: Single Drug Price (2015-2019)
10.3 Use: Chemotherapy Combination Sales Growth and Price
10.3.1 Global Use: Chemotherapy Combination Sales Growth (2015-2019)
10.3.2 Global Use: Chemotherapy Combination Price (2015-2019)
11 Global Atezolizumab Market Segment by Application
11.1 Global Atezolizumab Sales Market Share by Application (2015-2019)
11.2 Bladder Cancer Sales Growth (2015-2019)
11.3 Lung Cancer Sales Growth (2015-2019)
11.4 Advanced Triple-negative Breast Cancer Sales Growth (2015-2019)
11.5 Head and Neck Cancer Sales Growth (2015-2019)
11.6 Urothelial Carcinoma Sales Growth (2015-2019)
11.7 Renal Cell Carcinoma Sales Growth (2015-2019)
11.8 Hepatocellular Carcinoma (HCC) Sales Growth (2015-2019)
11.9 Other Sales Growth (2015-2019)
12 Atezolizumab Market Forecast (2020-2025)
12.1 Global Atezolizumab Sales, Revenue and Growth Rate (2020-2025)
12.2 Atezolizumab Market Forecast by Regions (2020-2025)
12.2.1 North America Atezolizumab Market Forecast (2020-2025)
12.2.2 Europe Atezolizumab Market Forecast (2020-2025)
12.2.3 Asia-Pacific Atezolizumab Market Forecast (2020-2025)
12.2.4 South America Atezolizumab Market Forecast (2020-2025)
12.2.5 Middle East and Africa Atezolizumab Market Forecast (2020-2025)
12.3 Atezolizumab Market Forecast by Type (2020-2025)
12.3.1 Global Atezolizumab Sales Forecast by Type (2020-2025)
12.3.2 Global Atezolizumab Market Share Forecast by Type (2020-2025)
12.4 Atezolizumab Market Forecast by Application (2020-2025)
12.4.1 Global Atezolizumab Sales Forecast by Application (2020-2025)
12.4.2 Global Atezolizumab Market Share Forecast by Application (2020-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
